Project Number ADDF-43 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2021 View Full Project Details for MIB-626 For Treatment of Mild Dementia Patients Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) r. Multi-target Researcher and Organization Principal Investigator Livingston, David Principal Investigator Livingston, David Awardee Organization Metro International Biotech Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement ADDF-Clinical Trial Program FY Overall Cost $3,000,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management
